A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients

Conditions

• Multiple Myeloma

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Accepted

Interventions

• Non-Interventional Study — OTHER
  Non-interventional study

Study Details

This study assesses the impact of cannabis (also commonly called marijuana, weed, or THC) use on quality of life among patients with multiple myeloma who are receiving chemotherapy. It also evaluates the potential benefits and harms of cannabis use.

Key Dates

Start date

Jan 21, 2026

Status verified

Feb 2026

Primary completion

Aug 22, 2030

Completion

Aug 22, 2030

Study Design

Enrollment

700 participants (estimated)

Arms

• Arm: Observational group I
  Patients complete surveys and undergo blood sample collection throughout the study.
• Arm: Observational group II
  Healthcare providers complete a survey on study.

Primary Outcome Measure

Longitudinal patterns in quality of life [ Time Frame: Up to one year ]

Locations (11)

Find similar trials in Goodyear, AZ

Related Studies

• Collection of Tissue Samples for Cancer Research
  Recruiting · National Cancer Institute (NCI) · Sacramento, California
• Integrated Cancer Repository for Cancer Research
  Recruiting · University of Nebraska · Greenwood Village, Colorado
• TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
  PHASE2 · Recruiting · American Society of Clinical Oncology · Birmingham, Alabama
• A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
  PHASE1 · Recruiting · Oncotherapeutics · Alhambra, California